ARN-3236 is potent, orally active and selective SIK2 inhibitor. ARN-3236 inhibited the growth of 10 ovarian cancer cell lines at an IC50 of 0.8 to 2.6 μmol/L.

YKL-06-061 is a potent and selective SIK (salt-inducible kinase) inhibitor.

MRIA9 is an ATP-competitive, pan Salt-Inducible kinase (SIK) and PAK2/3 inhibitor, with IC50 values of 516 nM, 180 nM and 127 nM for SIK1, SIK2 and SIK3, respectively.

WH-4-025 is a Salt-inducible kinase (SIK) inhibitor (WO2016023014 A2).